NCT03689946
Effect of Evolocumab on Coronary Atherosclerosis
See it on ClinicalTrials.gov ↗47 people
12.8%
87.2%
6 womenmiddle line = equal numbers41 men
- Phase
- PHASE3
- Paid for by
- Cedars-Sinai Medical Center
- Finished
- 2023-05-30
- Health conditions
- Cardiovascular Disease, Hyperlipidemia
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 61.8 years
- Age 65+
- 46.8%
- Weight (BMI)
- mean 26.8 kg/m^2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 85.1% · Asian 8.5% · Not reported 6.4% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · Black / African American 0% · More than one race 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnancy”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Women who are breastfeeding”
Study titles and rules are shown in their original English.